Home/ Supplements/ Lysine/ SuperImmune+

SuperImmune+

product on market Capsule Quantum Health Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

L-Lysine, Astragalus root, and olive leaf extract are studied for their roles in supporting immune function and antimicrobial activity. Current research provides limited evidence for the combined efficacy of these ingredients in a single formulation. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for SuperImmune+
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

1.5 Gram(s)
Market median: 500.0mg (159 products)
Market median: 470.0mg (230 products) 9 studies (A:3, B:3)
Market median: 500.0mg (115 products)

Other Ingredients

Hypromellose Water Microcrystalline Cellulose Magnesium Stearate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 3 capsules daily.

Warnings & Precautions

Warning: Keep out of reach of children.

If pregnant or breastfeeding or if you have a medical condition or if taking any medications or other supplements, consult a health professional before use.

Safety sealed for your protection

Formulation Notes

Vegetarian Power Formula

Vegetarian Power Formula

Lysine, Olive leaf, & Astragalus

Metadata

Product Details

UPC / SKU0 46985 00112 0
DSLD Entry Date2023-12-14
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID299886
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.